TAFAZZIN and Barth syndrome: DCMA has some phenotypic overlap with Barth syndrome, a disease caused by mutations in phospholipid-lysophospholipid transacylase, tafazzin (TAZ), encoding tafazzin, which is involved in the processing of cardiolipin [62,71,72].